Press release
Homocystinuria Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | Orphan Technologies, Travere Therapeutics, Synlogic
To Know in detail about the Homocystinuria market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Homocystinuria Market Forecast
https://www.delveinsight.com/sample-request/homocystinuria-market-new?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Homocystinuria Market Report:
• The Homocystinuria market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• Nearly 45,000 cases of Homocystinuria were reported to be widespread overall in the 7MM in 2022, according to DelveInsight data
• In the US, 14,000 cases of Homocystinuria were detected overall in 2022. The number of these cases is expected to rise between 2019 and 2032.
• Germany had the most total and frequent Homocystinuria cases among the EU4 and the UK in 2022, while Spain had the fewest cases.
• In May 2023, In the placebo-controlled Phase I/IICOMPOSE Study of pegtibatinase, a novel investigational enzyme replacement medication being studied for the treatment of classical homocystinuria (HCU), Travere Therapeutics reported encouraging results from cohort 6. Pegtibatinase has so far been well tolerated in most cases.
• Males and females are equally affected by homocystinuria owing to CBS deficiency, which is classified as an uncommon disorder by the National Organization for uncommon Disorders (NORD). According to population surveys, 1 in 344,000 people worldwide are thought to have homocystinuria. According to estimates, the prevalence in Germany is 1 in 17,500 cases
• The age group of 55-74 years old had the highest age-specific prevalence cases
• Key Homocystinuria Companies: Orphan Technologies, Travere Therapeutics, Synlogic, and others
• Key Homocystinuria Therapies: Pegtibatinase(TVT-058), SYNB1353, and others
• The Homocystinuria market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Homocystinuria pipeline products will significantly revolutionize the Homocystinuria market dynamics.
Homocystinuria Overview
The hereditary rare amino acid metabolism illness known as homocystinuria (HCU) is characterized by the body's improper processing of the amino acid methionine, which results in an abnormal build-up of homocysteine and its metabolites in the urine and blood. These metabolites are typically not detectable in blood or urine in significant amounts.
Get a Free sample for the Homocystinuria Market Report
https://www.delveinsight.com/report-store/homocystinuria-market-new?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Homocystinuria Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Homocystinuria Epidemiology Segmentation:
The Homocystinuria market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Homocystinuria
• Prevalent Cases of Homocystinuria by severity
• Gender-specific Prevalence of Homocystinuria
• Diagnosed Cases of Episodic and Chronic Homocystinuria
Download the report to understand which factors are driving Homocystinuria epidemiology trends @ Homocystinuria Epidemiology Forecast
https://www.delveinsight.com/sample-request/homocystinuria-market-new?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Homocystinuria Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Homocystinuria market or expected to get launched during the study period. The analysis covers Homocystinuria market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Homocystinuria Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Homocystinuria Therapies and Key Companies
• Pegtibatinase(TVT-058): Orphan Technologies/TravereTherapeutics
• SYNB1353: Synlogic
Discover more about therapies set to grab major Homocystinuria market share @ Homocystinuria Treatment Market
https://www.delveinsight.com/sample-request/homocystinuria-market-new?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Homocystinuria Market Strengths
• Improvement in diagnostic procedures like, New Born Screening Systems, has been a major factor in making the diagnosis of HCU much less complicated. Along with detecting elevated methionine (Met) level, analysis of total homocysteine (tHcy) as a second tier marker and calculating the Met/tHcy ratio is also recommended bylatest guidelines and this might leads to increase in diagnosis of HCU
Homocystinuria Market Opportunities
• The strong clinical development of novel therapeutics will have a positive effect on the market. Most of the groups and companies involved in research related to homocystinuria are also working towards improving the current diagnosis rate as well and this will provide the larger windows of opportunity for emerging therapies.
Scope of the Homocystinuria Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Homocystinuria Companies: Orphan Technologies, TravereTherapeutics, Synlogic, and others
• Key Homocystinuria Therapies: Pegtibatinase(TVT-058), SYNB1353, and others
• Homocystinuria Therapeutic Assessment: Homocystinuria current marketed and Homocystinuria emerging therapies
• Homocystinuria Market Dynamics: Homocystinuria market drivers and Homocystinuria market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Homocystinuria Unmet Needs, KOL's views, Analyst's views, Homocystinuria Market Access and Reimbursement
To know more about Homocystinuria companies working in the treatment market, visit @ Homocystinuria Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/homocystinuria-market-new?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Homocystinuria Market Report Introduction
2. Executive Summary for Homocystinuria
3. SWOT analysis of Homocystinuria
4. Homocystinuria Patient Share (%) Overview at a Glance
5. Homocystinuria Market Overview at a Glance
6. Homocystinuria Disease Background and Overview
7. Homocystinuria Epidemiology and Patient Population
8. Country-Specific Patient Population of Homocystinuria
9. Homocystinuria Current Treatment and Medical Practices
10. Homocystinuria Unmet Needs
11. Homocystinuria Emerging Therapies
12. Homocystinuria Market Outlook
13. Country-Wise Homocystinuria Market Analysis (2019-2032)
14. Homocystinuria Market Access and Reimbursement of Therapies
15. Homocystinuria Market Drivers
16. Homocystinuria Market Barriers
17. Homocystinuria Appendix
18. Homocystinuria Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Homocystinuria Pipeline https://www.delveinsight.com/report-store/homocystinuria-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Homocystinuria Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Homocystinuria market. A detailed picture of the Homocystinuria pipeline landscape is provided, which includes the disease overview and Homocystinuria treatment guidelines.
Homocystinuria Epidemiology https://www.delveinsight.com/report-store/homocystinuria-epidemiology-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Homocystinuria Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Homocystinuria epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
Chronic Constipation Market https://www.delveinsight.com/report-store/chronic-constipation-market
DelveInsight's "Chronic Constipation Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Constipation, historical and forecasted epidemiology as well as the Chronic Constipation market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Fungal pneumonia Market
https://www.delveinsight.com/report-store/fungal-pneumonia-market
DelveInsight's "Fungal Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Fungal Pneumonia, historical and forecasted epidemiology as well as the Fungal Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Spinal Muscular Atrophy Market
https://www.delveinsight.com/report-store/spinal-muscular-atrophy-market
DelveInsight's "Spinal Muscular Atrophy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Spinal Muscular Atrophy, historical and forecasted epidemiology as well as the Spinal Muscular Atrophy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Morquio Syndrome Market
https://www.delveinsight.com/report-store/morquio-syndrome-market
DelveInsight's "Morquio Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Morquio Syndrome, historical and forecasted epidemiology as well as the Morquio Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Diabetic neuropathy Market
https://www.delveinsight.com/report-store/diabetic-neuropathy-market
DelveInsight's "Diabetic Neuropathy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Diabetic Neuropathy, historical and forecasted epidemiology as well as the Diabetic Neuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Homocystinuria Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | Orphan Technologies, Travere Therapeutics, Synlogic here
News-ID: 3298422 • Views: …
More Releases from DelveInsight Business Research
Global General Surgery Devices Market is expected to grow at a CAGR of 6.3% by 2 …
General Surgery Devices Market Overview
The Global General Surgery Devices Market is projected to grow at a CAGR of 6.34% from 2025 to 2032, driven by the rising burden of chronic diseases, increasing surgical interventions, and the adoption of robotic-assisted and minimally invasive techniques. Covering instruments such as handheld tools, electrosurgical devices, laparoscopic systems, wound closure products, and disposables, these devices play a critical role in diverse procedures, including orthopedic, cardiovascular,…
Intratumoral Cancer therapies Market Outlook 2034 - Clinical Trials, Market Size …
Intratumoral Cancer Market Summary
Intratumoral cancer therapies involve direct delivery into tumors, enabling localized targeting with minimal damage to surrounding tissue. Within the 7MM, non-melanoma cancers represent the largest share of cases and are expected to rise at ~2% annually, while in the US, breast cancer accounts for about 30% of cases with a growing incidence rate for intratumoral therapies. Currently, IMLYGIC is the only FDA-approved intratumoral therapy for melanoma, holding…
Bispecific and Trispecific Antibodies Market Projected to Experience Significant …
Bispecific antibodies represent an innovative class of therapies designed to address complex diseases by simultaneously binding two targets with a single molecule. Most currently approved bispecifics are for oncology, particularly multiple myeloma and diffuse large B-cell lymphoma (DLBCL). Beyond oncology, only HEMLIBRA and VABYSMO are approved for conditions such as hemophilia A, wet age-related macular degeneration, and diabetic macular edema, while KIMMTRAK is approved for uveal melanoma. The pipeline remains…
Narcolepsy Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Update …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Narcolepsy pipeline constitutes 10+ key companies continuously working towards developing 12+ Narcolepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Narcolepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed…
More Releases for Homocystinuria
Homocystinuria Pipeline Overview: Biopharma Innovators Target Novel Approaches t …
The therapeutic landscape for homocystinuria, a rare inherited metabolic disorder caused by deficiencies in enzymes involved in methionine metabolism (most commonly cystathionine beta-synthase), is poised for meaningful evolution. While dietary management, vitamin supplementation, and betaine remain the current standard of care, significant unmet needs persist in preventing serious complications such as vascular events, skeletal abnormalities, and neurological impairment. Emerging treatments aim to go beyond symptomatic management to address underlying metabolic…
Homocystinuria Market Growth, Trends & Forecast 2025 | Leading key players - Tra …
The Global Homocystinuria Market is expected to reach at a Significant CAGR during the forecast period 2024-2031.
Homocystinuria Market report, published by DataM Intelligence, delivers detailed insights and analysis on major market trends, growth prospects, and emerging challenges. With a strong focus on providing actionable intelligence, DataM Intelligence enables businesses to make well-informed decisions and maintain a competitive edge. By blending both qualitative and quantitative research approaches, the company offers thorough…
Homocystinuria Market: Projected Positive Growth Trends through 2024-2031 - Trav …
The Homocystinuria Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.
Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/homocystinuria-market
What is the projected growth…
Homocystinuria Market Size, Share, Trends Analysis And Forecast 2024-2033
Market Definition
Homocystinuria is an inherited metabolic disorder caused by the body's inability to break down an amino acid called homocysteine. It is a rare condition, affecting approximately one in every 100,000 to 200,000 people worldwide.
Market Outlook
When homocysteine is not broken down properly, it accumulates in the blood and causes a variety of health problems. Those affected by homocystinuria are unable to convert the essential amino acid methionine to cysteine, which…
Managing Homocystinuria: A Decade Forecast for the Market (2023-2033)
Market Outlook:
The Homocystinuria Market envisions a decade of balanced health with a positive outlook from 2023 to 2033. As awareness of rare genetic disorders grows and advancements in medical research continue, the market anticipates significant progress in addressing Homocystinuria. This transformative period is characterized by factors such as increasing diagnostic capabilities, the evolution of targeted therapies, and ongoing efforts to improve patient outcomes. The forecast marks a decade of opportunities…
Homocystinuria Market Analysis, Epidemiology, Trends and Forecast till 2023-2033
IMARC Group has recently released a report titled "Homocystinuria Market: Analysis of Epidemiology, Industry Trends, Size, Share, and Future Forecast (2023-2033)" that presents a comprehensive assessment of the homocystinuria market. The report provides an extensive overview of the latest market trends, growth prospects, investment opportunities, and industry outlook, as well as an in-depth analysis of the disease landscape, market size, and growth trends. Furthermore, the report offers an analysis of…
